ENCORE Research Group
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
ENCORE Research Group - overview
Established
1997
Location
Jacksonville, FL, US
Primary Industry
Pharmaceuticals
About
Founded in 1997 and based in Florida, US, ENCORE Research Group operates as a network of independent, multi-specialty clinical research sites across Florida. In June 2024, Priv Inc. Flourish Research, a portfolio company of New MainStream Capital, acquired ENCORE Research Group. The firm operates research sites specializing in Phase 1-4 clinical trials on both inpatient and outpatient studies.
Their in-house developed Clinasyst Next Gen CTMS manages a patient database exceeding 100,000 individuals. ENCORE's network includes local physicians, providing comprehensive trial management in more than 50 therapeutic areas. The organization operates seven locations, and over 2500 clinical trials to support advancements in medical treatments.
Current Investors
Flourish Research
Primary Industry
Pharmaceuticals
Sub Industries
Pharmaceutical Research & Development
Website
www.encoredocs.com
Company Stage
Add-on
Total Amount Raised
Subscriber access only
ENCORE Research Group - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Add-on | Completed | ENCORE Research Group | - |
Displaying 1 - 1 of 1
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.